Test surge multiple award IDIQ

Active Awarded Last action

Contract number
75D30124D20078
Awardee
Awarding agency
Task orders
4 $3,793,222 obligated

Award facts

Combined order value
  • $3,793,222 Current, with exercised options
  • $7,077,230 Potential, with all options
Last date to order 43% complete
IDV ceiling 3% used
$118,000,000.00
Maximum order
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Contracting staff
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

CDC Pittsburgh awarded a multiple-award indefinite-delivery contract to Laboratory Corporation of America with a ceiling of $118 million on September 6, 2024. No set-aside applies. The contract, titled Test Surge Multiple Award IDIQ and established under Executive Order 14398, has an ultimate completion date of September 5, 2029.

Work is performed in Burlington, North Carolina. The IDIQ supports diagnostic testing and laboratory analysis capabilities for CDC epidemiological and laboratory operations, including metagenomic next-generation sequencing, reference laboratory testing, specimen analysis, and diagnostic test development.

Four delivery orders have been issued under this IDIQ. The largest is a $4.29 million firm-fixed-price order awarded September 6, 2024, with completion by September 5, 2029. A $2.57 million metagenomic next-generation sequencing delivery order was issued May 3, 2026, for completion by April 14, 2028. A $145,000 firm-fixed-price order was awarded January 15, 2025, with completion by May 15, 2025. An H5 test-creation task order valued at $75,750 was awarded September 6, 2024, priced on a time-and-materials basis with completion by September 5, 2025.

Laboratory Corporation of America, a for-profit diagnostic testing and medical laboratory services provider, holds no small-business designations. The company operates as a prime contractor and reports zero average subcontractor hours on its federal service contracts.

Task orders

Task order Ordering agency Obligated Awarded
Metagenomic next-generation sequencing (mngs) 75D30126F00004 CDC Pittsburgh $2,570,000
Test surge multiple award IDIQ 75D30125F00003 CDC Pittsburgh $145,000
H5 test creation task order 75D30124F00002 CDC Pittsburgh $75,750
Test surge multiple award IDIQ 75D30124F00001 CDC Pittsburgh $1,002,472

Transactions

Action Obligated Date
Other Administrative Action P00001 · EO 14398 $0
Original award $0

Quick answers

Who was awarded contract 75D30124D20078?

75D30124D20078 was awarded to Laboratory Corporation Of America by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 6, 2024.

How much is contract 75D30124D20078 worth?

Orders under 75D30124D20078 have obligated $3,793,222. Their combined potential value, with all options, is $7,077,230. 75D30124D20078's own ceiling is $118,000,000. A single order can be worth up to $5,000,000.

How many orders have been placed under contract 75D30124D20078?

4 orders have been placed under 75D30124D20078, the latest on May 3, 2026.

Who can order from contract 75D30124D20078?

75D30124D20078 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75D30124D20078 part of a contract vehicle?

Yes. 75D30124D20078 is part of Test Surge and Data Sharing.

Was contract 75D30124D20078 competed?

The extent of competition for 75D30124D20078 was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV